Lymphocyte depletion during treatment with intensive chemotherapy for cancer

Abstract

Recently we have observed an increased incidence of opportunistic infections in patients treated with intensive chemotherapy for cancer. Because T-cell depletion is associated with similar clinical events in human immunodeficiency virus infection and after bone marrow transplantation, we have analyzed peripheral blood lymphocyte populations in a series of patients during treatment with intensive chemotherapy for cancer. Although neutrophil, monocyte, and platelet numbers consistently recovered to greater than 50% of pretreatment values after each sequential cycle of therapy, lymphocyte numbers did not recover within the same time period. B cells decreased rapidly from a mean value of 149 +/- 46/mm3 before chemotherapy to 4 +/- 1/mm3 during chemotherapy (P = .01). CD4+ T cells decreased from a mean of 588 +/- 76/mm3 before chemotherapy to 105 +/- 28/mm3 during chemotherapy (P = .0002) and CD8+ T cells decreased from a mean of 382 +/- 41/mm3 before chemotherapy to 150 +/- 46/mm3 during chemotherapy (P = .0009). Natural killer cell numbers did not show significant declines (171 +/- 30/mm3 before, 114 +/- 24/mm3 during, P = .19). Based on the history of opportunistic complications in patients with other disorders who display similar degrees of CD4+ T-cell lymphopenia and preliminary observations in this population, immune incompetence could surface as a dose-limiting toxicity for highly dose-intensive chemotherapy regimens.

How to manage vaccinations in children with cancer

“…Immunosuppression in children with cancer can be due to the illness itself, to the anti‐neoplastic therapy administered or to both 1–4. The effect of therapy is evident on all the hematological cellular lines but some differences are reported, especially regarding recovery time.…”

Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapy

“…Chemotherapy for solid tumors can induce changes in lymphocyte subpopulations. These aspects have been evaluated previously in order to study lymphopoiesis during chemotherapy‐induced myelosuppression (8, 9). Colony‐stimulating factors (CSFs) can reduce the duration of neutropenia but has little practical benefit (10).…”

Changes in cellular immunity during chemotherapy for testicular cancer

“…Intensive chemotherapy induces a dramatic depletion of lymphocytes. Several researchers have reported that the extent of lymphocyte depletion during chemotherapy depends on the specific protocol used 16,17 . Indeed, it is well known that cyclophosphamide has a greater effect on lymphocyte populations than other drugs 18 .…”